Why One Fund Sold $5 Million of Chart Industries Stock

Iridian Asset Management sold 23,051 shares of Chart Industries (GTLS) in Q4 — an estimated $4.67 million using quarterly average pricing — finishing the quarter with 6,326 shares worth $1.30 million and a reported quarter-end position decline of $4.58 million; the position fell from 2.3% to 0.48% of reportable AUM. Chart shares were $207.49 as of Jan 22 (market cap $9.33bn), with TTM revenue $4.29bn and net income $66.7m; operationally Chart reported record Q3 orders of $1.68bn (+44% YoY), backlog of $6.05bn, adjusted EBITDA $277m and FCF $94.7m despite merger-related expenses, and is under a $210/share cash acquisition agreement with Baker Hughes — a dynamic that likely capped upside and prompted the trim.

Analysis

Market structure: The Baker Hughes (BKR) cash deal for Chart Industries (GTLS) effectively transfers market share and a $6.05B backlog into BKR, reducing GTLS free float and capping GTLS upside near $210. Near-term winners: BKR (integration/cross-sell optionality) and arbitrageurs; losers: standalone cryogenic peers (e.g., Flowserve/FLS) facing a stronger consolidated competitor and potential margin pressure. Liquidity effects: Iridian’s $4.7M sell reduced supply-side support, but overall float shrinkage tightens liquidity and compresses GTLS implied volatility ahead of close.

Risk assessment: Largest tail risks are deal break (financing, antitrust, material-adverse-change) or delayed close — both would likely drop GTLS >10% intraday and widen BKR credit spreads by 50–150bp. Timeframes: immediate (days) = volatility compression and small selling; short-term (3–9 months) = regulatory/financing outcomes and deal close; long-term (12+ months) = realized synergies or integration disappointments affecting BKR EPS by ±5–15%. Hidden dependency: value hinges on backlog convertibility and aftermarket retention post-integration, not just headline revenue.

Trade implications: Preferred tactical is risk arb: long GTLS cash up to $208 (limit) sized 1–2% NAV targeting $210 within 3–6 months, trimming if spread < $1 or new adverse filings appear. Options: sell a 30–60 day GTLS $210/$215 call spread to collect premium (size 0.5–1% NAV) given low IV; avoid large directional BKR equity longs pre-close — consider buying BKR credit protection if 3–5yr spread widens >50bp. Sector: rotate 2–3% into industrial-gas/hydrogen leaders (LIN, APD) to capture secular LNG/H2 demand over 6–18 months.

Contrarian angles: The market may underprice recurring aftermarket value and service margins in the $6B backlog — if conversion >50% and aftermarket retention >70%, intrinsic value >$210, opening upside if alternative bidder emerges. Conversely, consensus underestimates integration risk: if synergies <50% of plan or backlog cancels >20%, BKR downside could be material. Watch DOJ/FTC filing timestamps and BKR debt prospectus — these two documents will reprice both equity and credit within 30–90 days.

Key Decisions for Investors

• Establish a 1–2% NAV risk-arb long in GTLS at or below $208 per share, target $210 cash within 3–6 months; cut to zero if GTLS falls >10% on deal-break news or if BKR announces inability to finance.
• Sell a 30–60 day GTLS $210/$215 call credit spread sized 0.5–1% NAV to harvest IV premium; close if spread to deal price narrows < $1 or if regulatory filings extend timeline beyond 9 months.
• Avoid initiating a material long in BKR pre-close; instead, buy 3–5yr BKR credit protection (CDS or bond puts) if corporate spreads widen >50bp, or consider a small 0.5–1% short equity if BKR equity moves >8% above pre-deal baseline on financing concerns.
• Rotate 2–3% NAV from high-beta small caps (e.g., ACVA, HGV) into industrial-gas/hydrogen leaders (Linde LIN, Air Products APD) for a 6–18 month horizon to capture secular LNG/H2 demand, trimming if energy capex indicators fall >15% YoY.